Protalix BioTherapeutics logo
Protalix BioTherapeutics PLX
$ 1.65 -2.37%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Protalix BioTherapeutics Total Liabilities 2011-2024 | PLX

Annual Total Liabilities Protalix BioTherapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
50.9 M 66.4 M 79.7 M 95 M 116 M 114 M 104 M 92.2 M 86.4 M 134 M 140 M 82.1 M 77.9 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
140 M 50.9 M 95.2 M

Quarterly Total Liabilities Protalix BioTherapeutics

2024-Q3 2024-Q2 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
29.1 M 63 M 49.3 M 49.4 M 65.6 M 66.4 M 68.2 M 70.5 M 75.9 M 79.7 M 83.3 M 104 M 88.3 M 95 M 95 M 95 M 95 M 116 M 116 M 116 M 116 M 114 M 114 M 114 M 114 M 102 M 102 M 102 M 102 M 92.2 M 92.2 M 92.2 M 92.2 M 86.4 M 86.4 M 86.4 M 86.4 M 134 M 134 M 134 M 134 M 140 M 140 M 140 M 140 M 82.1 M 82.1 M 82.1 M 82.1 M 77.9 M 77.9 M 77.9 M 77.9 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
140 M 29.1 M 95.3 M